<DOC>
	<DOCNO>NCT01711099</DOCNO>
	<brief_summary>Clinical research justify effectiveness Extracorporeal Shockwave Myocardial Revascularization ( ESMR ) Therapy treatment patient reversible myocardial ischemia secondary Coronary Artery Disease ( CAD ) therapy resistant stable angina pectoris .</brief_summary>
	<brief_title>Efficacy Extracorporeal Shockwave Myocardial Revascularization</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Patient sign Informed Consent Form . Patient 's current past medical condition status assess use previous medical history , complete physical examination physician ( principle investigator 's ) medical opinion . Patient diagnose chronic angina pectoris least 6 week . Diagnosis base medical history , complete physical examination , core lab . Patients longer receive benefit additional revascularization procedure ( i.e . CABG Angioplasty ) . Certification make Heart Team . Patient demonstrate Exercise Tolerance Time ( ETT ) duration &lt; 10 minute Modified Bruce protocol . Patient least one document myocardial segment reversible ischemia . Patient optimum medical therapy angina least 6 week . The optimal treatment plan tailor person 's age , presence medical condition , lifestyle , medication side effect , etc . Medical therapy stable angina include ACEinhibitors , Nitrates , Beta Blockers Calcium Channel Blockers , trimetazidine , ivabradin . Combination 3 mention drug consider optimum medical therapy . Patient echocardiographic acoustic window target area myocardium utilize one follow view : apical 2 chamber view ( 2CH ) , apical 4 chamber view ( 4CH ) , modify parasternal long axis view ( LAX ) parasternal short axis view ( SAX ) . Patient substantially benefit additional revascularization procedure additional CABG angioplasty therapy . This determination make certified Heart Team . Patient active endocarditis , myocarditis pericarditis . Patient moderately severe severe valvular disease . Patient known intraventricular thrombus . Patients active nonactive implantables , pacemaker , defibrillator , abandon lead , electrode . Patient shock wave apply implanted device release substance medication periphery ( insulin pump ) . Patient pregnant . Patient severe chronic lung disease ( emphysema , pulmonary fibrosis ) difficult access ultrasonic acoustic window . Patients shock wave apply area heal fracture . Patients shock wave apply area bone growth . Patients shock wave apply area malignancy . Prior invasive malignancy , except nonmelanomatous skin cancer malignancy document diseasefree survival minimum 5 year . By physician decision underlie concomitant disease circumstance may negatively influence management patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>